from the august/05 nomura figure (up to the time of the german order) we know the forecast sale (which must hv been verified with gsk before publication) was gbp20m=aud35m for 2005. extrapolate from the nomura figure add french/aus orders and other suspects you are looking at min aud$50-65m for 2005.
GlaxoSmithKline's Relenza Sales Seen GBP20M Tuesday, August 23, 2005 3:22:44 AM ET Dow Jones Newswires
0715 GMT [Dow Jones] Nomura says GlaxoSmithKline (GSK) has limited supply of Relenza flu product. Notes company is planning to scale up production substantially, but adds current production process involves several outside parties and a lead time of around 12 months. Sales of Relenza could, however, reach GBP20M this year with the recently announced 1.7M dose contract with the German government (pl see abv link for full article)
BTA Price at posting:
0.0¢ Sentiment: None Disclosure: Not Held